Interview with the Innovators

This Interview with the Innovator video features breast cancer nurse navigators Emily Beard, RN, BSN, OCN, CBCN, and Melissa Simon, BSN, RN, OCN, CBCN, ONN-CG, as they discuss ovarian function suppression, how patients tolerate side effects, and educating patients on expectations of treatment.

Best Practices in OFS in Premenopausal Breast Cancer

Ovarian Suppression: What Are Some of the Important Questions That Women Ask?

Emily Beard, RN, BSN, OCN, CBCN, Melissa Simon, BSN, RN, OCN, CBCN, ONN-CG

Video Library

Emily Beard, RN, BSN, OCN, CBCN, and Melissa Simon, BSN, RN, OCN, CBCN, ONN-CG, examine fertility issues associated with ovarian function suppression and the psychosocial impact it has on young breast cancer patients.

Best Practices in OFS in Premenopausal Breast Cancer

Setting Patients’ Expectations When They Are Prescribed Combination Therapy for Premenopausal Breast Cancer

Emily Beard, RN, BSN, OCN, CBCN, Melissa Simon, BSN, RN, OCN, CBCN, ONN-CG

Video Library

This Interview with the Innovator video features two breast cancer nurse navigators, Emily Beard, RN, BSN, OCN, CBCN, and Melissa Simon, BSN, RN, OCN, CBCN, ONN-CG, reviewing combination therapy with ovarian function suppression and its effects in breast cancer patients, including the importance of setting up-front expectations of treatment.

Best Practices in OFS in Premenopausal Breast Cancer

Oncology Nurse Navigators Discuss Their Best Practices to Encourage Premenopausal Breast Cancer Patients to Adhere to Their Therapy

Emily Beard, RN, BSN, OCN, CBCN, Melissa Simon, BSN, RN, OCN, CBCN, ONN-CG

Video Library

Emily Beard, RN, BSN, OCN, CBCN, and Melissa Simon, BSN, RN, OCN, CBCN, ONN-CG, highlight the challenges with ovarian function suppression side effects patients face and explore tactics to encourage adherence to treatment.

Best Practices in OFS in Premenopausal Breast Cancer

Sexual Heath Dysfunction Associated With Ovarian Function Suppression: How Do I Start the Discussion With My Premenopausal Breast Cancer Patient?

Emily Beard, RN, BSN, OCN, CBCN

Video Library

Gain insights from Emily Beard, RN, BSN, OCN, CBCN, breast oncology nurse navigator, in this Interview with the Innovator video on communication techniques to discuss sensitive topics with breast cancer patients including sexual health dysfunction associated with ovarian function suppression.

Best Practices in OFS in Premenopausal Breast Cancer

Ovarian Function Suppression Side Effects to Monitor & Report to HCP

Emily Beard, RN, BSN, OCN, CBCN, Melissa Simon, BSN, RN, OCN, CBCN, ONN-CG

Video Library

In this Interview with the Innovator video, Melissa Simon, BSN, RN, OCN, ONN-CG, and Emily Beard, RN, BSN, OCN, CBCN, discuss common and expected side effects with ovarian function suppression as well as adverse side effects to monitor and report to a healthcare provider.

IWTI 2022

Navigating Patients with Chronic Lymphocytic Leukemia: An interview with Nikki Barkett, BSN, RN, OCN, and Chelsea Passwater, DNP, RN, AGCNS-BC, OCN, of the AONN+ CLL CAPE Initiative

September 2022 Vol 13, No 9

Chronic lymphocytic leukemia (CLL) is the most common adult leukemia. The American Cancer Society estimates over 20,000 new CLL cases and over 4000 attributed deaths in 2022.

PET/CT Imaging in Prostate Cancer Patients

Insights into the Prostate Cancer Imaging Landscape

Steven Rowe, MD, PhD

Video Library

Dr Steven Rowe continues his discussion of PYLARIFY^® (piflufolastat F 18) imaging, with a focus on results from the OSPREY clinical trial in pre-prostatectomy patients.

PET/CT Imaging in Prostate Cancer Patients

Results from the OSPREY Trial in Pre-Prostatectomy Patients

Steven Rowe, MD, PhD

Video Library

Dr Steven Rowe continues his discussion of PYLARIFY^® (piflufolastat F 18) imaging, with a focus on results from the OSPREY clinical trial in pre-prostatectomy patients.